Yash Singh
CIK 1793157 · View on SEC EDGAR ↗
First SEC filing: Nov. 5, 2019 · Latest: Nov. 5, 2019
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 31, 2019 | HBIO | A | 86,614 | — | — | 86,614 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 31, 2019 | HBIO | A | 39,286 | — | — | 39,286 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 31, 2019 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (86,614) | $2.80 | Oct. 31, 2029 | 86,614 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $45,539 | — | — | — | — | — | — | $274,576 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.